Authors





Richard Lynen, MD, MBA

Latest:

Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine Devices

This analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.


Kenneth C Hohmeier, PharmD, Carol Ann Wilson, PharmD

Latest:

Proper Safety Measures to Protect Pharmacy Staff During COVID-19 Outbreak

Key best practices for protecting pharmacy personnel during the COVID-19 pandemic.


Christine Potkul

Latest:

Persistent and Severe Postnatal Depression Increase Children's Risk of Development Issues

The results of a recent study show that persistent postnatal depression lasting 6 months or longer can have severe implications on child development.


Sherif Abdou, PharmD

Latest:

Biologic Management for IBD

With increased specialty medication prescribing, associated costs, and the interest of health systems to establish specialty pharmacies for improved patient care, it is vital to define the pharmacist's role within the patient's health care team.


Mark W. Ward, BA

Latest:

Early View of Ampyra and Gilenya Use by MS Patients

Uptake of the new oral agents gilenya and Ampyra may be expected to increase rapidly in the future, if for largely different reasons.


Ujjaval J. Pathak, 2016 PharmD Candidate, Temple University

Latest:

Head Lice Treatment: Perspective for Pharmacists

An estimated 6 to 12 million individuals in the United States develop head lice each year, with most cases occurring in children ages 3 to 11.


Nick Calla, RPh, JD

Latest:

Specialty Pharmacies and Baby Boomers: Adapting to Meet the Changing Needs of the New Older American

The Baby Boomer generation will stretch the resources of the US health care system, with technology-driven behaviors that force a reevaluation of the delivery of care.


Priyam Vora, AJMC

Latest:

TBO-Filgrastim Offers Significant Cost Savings Over Filgrastim in Myeloma Treatment

Bone marrow stimulant helps the body make white blood cells after receiving cancer medications.


Charles Ng, PharmD-MBA Candidate 2017

Latest:

5 Things Happening in Pharmacy Right Now

Stay up-to-date with the hottest news in pharmacy!


Renée J.G. Arnold, PharmD, RPh

Latest:

Cost-Effectiveness of Extended-Release Carbidopa-Levodopa for Advanced Parkinson's Disease

Existing levodopa therapies for Parkinson’s disease often provide inadequate symptom control after prolonged treatment. This study assessed the cost-effectiveness of an extended-release carbidopa-levodopa formulation (IPX066).


Kevin Kunzmann

Latest:

Frontline Drugs Vancomycin, Fidaxomicin Found to Benefit Transplant Patients With C Difficile

Adult patients with Clostrioides difficile infection who received hematopoietic stem cell transplant also benefitted from frontline medications fidaxomicin or oral vancomycin.


Jason Harris

Latest:

Examining Treatment Strategies in in Platinum-Sensitive Ovarian Cancer

Physicians treating patients with platinum-sensitive ovarian cancer can choose from a range of therapies, including doublet chemotherapy with or without bevacizumab (Avastin) and PARP inhibitors.


Nicole Leonard

Latest:

News & Trends

Pharmacists can keep up-to-date on a new requirement in California to provide proof of a Tdap booster for middle and high school students, as well as new studies on the obesity epidemic, asthma care, teen vaccination rates, autism research, and teen prgnancy.


Kathy H. Fraeman, MS

Latest:

Synchronization of Treatment With Erythropoiesis-Stimulating Agents and Chemotherapy

In outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.


Riza Usta, Nazmin J Khalifa

Latest:

Moving Health Care into the Future: Proposal for Pharmacist-led Refill Authorizations

Pharmacist-led refill authorizations are a practical solution to the nation’s health care crisis, helping to improve quality while reducing costs as well as saving physicians’ time.


Tyler Ratliff, PharmD

Latest:

Provision of Diabetes Sick-Day Plans in the Community Pharmacy

As community pharmacists, we are often the most accessible members of the health care team.


Kelly Harbourt, PharmD, BCPS

Latest:

Exploring the Critical Elements of Hyperkalemia: A Hospital Pharmacist's Perspective

This Continuing Education activity is supported by an educational grant from Relypsa, Inc.


Jill Drury, PharmD

Latest:

Students Should Seize the Opportunity to Host Brown Bag Consults

The current health care environment makes it challenging for student pharmacists to find ways to shine. But the coronavirus disease 2019 (COVID-19) pandemic has given students the opportunity to assist pharmacists with new workflow issues and prioritize patient volume.


Catherine M. Kew, PharmD Candidate

Latest:

Neuropathic Pain: A Glimpse Inside the Unabating Affliction

Originating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges.


Kristen Nicita, PharmD

Latest:

Effect of Dispensing Supply on Pravastatin Refill Adherence

In uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.


Kenneth Maxik, MBA, MBB

Latest:

Store, Handle, and Administer Vaccines Safely to Prevent Errors

Pharmacists should stay abreast of changes in formulations and recommendations, foster communication with their staff, and plan proactively.


Thom Kim Nguyen, PharmD, BCPS

Latest:

Making Sense of Allergic Rhinitis: Key Points in Optimizing Patient Counseling Strategies

Pharmacists can learn to apply counseling strategies to help address common patient questions to achieve optimal symptom relief in allergic rhinitis.


Brody McConnell, PharmD

Latest:

Occupational Rhinitis: A Hard Day's Work for Noses

About 5% to 15% of the global workforce is estimated to have an occupational disease.


Stefanie Bala, PharmD Candidate

Latest:

Rx Product News: Profile: A Closer Look at New FDA Actions: Selzentry

This novel agent for HIV patients received accelerated FDA approval.


Marc Boutin, JD, Chief Executive Officer, National Health Council

Latest:

Going the Extra Step to Enhance the Exchanges

Which states can policy makers look to as leaders in creating patient-focused health insurance markets? A series of state-by-state progress reports holds the answer.


Danielle R. Haskins, PharmD Candidate, University of Connecticut School of Pharmacy

Latest:

Natural Medicines: What Is Their Role in Parkinson's Disease Management?

Researchers from Jawaharlal Nehru University in New Delhi, India studied an array of natural medicinal products with beneficial effects on mitochondria or redox stabilization.


David Dakwa, PharmD/MBA candidate

Latest:

340B Compliance: Tips to Maintaining a Successful Program

Since its induction in 1992, the 340B Drug Pricing Program has been responsible for helping eligible covered entities stretch scarce federal resources and increase services to patients of the covered entity.